IL-1β and IL-18, both by-products of NLRP3 inflammasome activation, appear to have a relevant contribution in the occurrence and propagation of atherosclerosis which is corroborated by abundant data obtained from the evaluation of atherosclerotic plaques in rodents and humans [26,31]. The gene discussed is NLRP3; the disease is atherosclerosis.